Physician profile
Mayank Patel
NPI 1336191220
$645.35
in general payments reported to CMS, 2019-2025
7 companies · $101 in 2025
The $101 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.33 · 2020: $152 · 2021: $69.63 · 2022: $137 · 2023: $57.83 · 2024: $59.56 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $218.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $443.75 | 2019-2025 | Bexsero, Rotarix, Pediarix |
| Pfizer INC. | $65.60 | 2019-2025 | |
| Sanofi Pasteur INC. | $45.21 | 2024 | |
| Hologic Sales and Service, LLC | $33.60 | 2021 | |
| Aytu Biopharma, INC. | $24.85 | 2025 | |
| Lnhc, INC | $16.32 | 2025 | Zelsuvmi |
| Alk-Abello, INC | $16.02 | 2023 | Ragwitek, Grastek, Odactra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mayank Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.